Pathological work-up of sentinel lymph nodes in breast cancer. Review of current data to be considered for the formulation of guidelines

G. Cserni, I. Amendoeira, N. Apostolikas, J. P. Bellocq, S. Bianchi, G. Bussolati, W. Boecker, B. Borisch, C. E. Connolly, T. Decker, P. Dervan, M. Drijkoningen, I. O. Ellis, C. W. Elston, V. Eusebi, D. Faverly, P. Heikkila, R. Holland, H. Kerner, J. KulkaJ. Jacquemier, M. Lacerda, J. Martinez-Penuela, C. De Miguel, J. L. Peterse, F. Rank, P. Regitnig, A. Reiner, A. Sapino, B. Sigal-Zafrani, A. M. Tanous, S. Thorstenson, E. Zozaya, C. A. Wells

Research output: Contribution to journalReview articlepeer-review

200 Scopus citations

Abstract

Controversies and inconsistencies regarding the pathological work-up of sentinel lymph nodes (SNs) led the European Working Group for Breast Screening Pathology (EWGBSP) to review published data and current evidence that can promote the formulation of European guidelines for the pathological work-up of SNs. After an evaluation of the accuracy of SN biopsy as a staging procedure, the yields of different sectioning methods and the immunohistochemical detection of metastatic cells are reviewed. Currently published data do not allow the significance of micrometastases or isolated tumour cells to be established, but it is suggested that approximately 18% of the cases may be associated with further nodal (non-SN) metastases, i.e. approximately 2% of all patients initially staged by SN biopsy. The methods for the intraoperative and molecular assessment of SNs are also surveyed.

Original languageEnglish
Pages (from-to)1654-1667
Number of pages14
JournalEuropean Journal of Cancer
Volume39
Issue number12
DOIs
StatePublished - Aug 2003
Externally publishedYes

Keywords

  • Breast cancer
  • Frozen section
  • Intraoperative cytology
  • Isolated tumour cell
  • Micrometastasis
  • Molecular analysis
  • Non-sentinel node metastasis
  • Occult metastasis
  • Sentinel lymph nodes
  • Survival

Fingerprint

Dive into the research topics of 'Pathological work-up of sentinel lymph nodes in breast cancer. Review of current data to be considered for the formulation of guidelines'. Together they form a unique fingerprint.

Cite this